Standout Papers

The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors 2011 2026 2016 2021 618
  1. The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors (2011)
    Ben Lawrence, Björn Gustafsson et al. Endocrinology and Metabolism Clinics of North America

Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Interaction of the Vagus Nerve and Serotonin in the Gut–Brain Axis
2025 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
9 intermediate papers

Works of Ben Lawrence being referenced

PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
2020
The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors
2011
and 3 more

Author Peers

Author Last Decade Papers Cites
Ben Lawrence 908 927 172 552 44 1.2k
J-Y. Scoazec 1207 1269 257 807 20 1.6k
Merten Hommann 784 834 275 523 56 1.5k
Daniel Kaemmerer 936 909 238 615 64 1.4k
Stephan U. Goebel 928 1121 199 733 30 1.4k
Henning Jann 1041 1108 46 700 58 1.3k
Marc J. Berna 833 979 287 624 26 1.5k
Viktor Johanson 533 610 113 439 43 994
Mark Sawicki 500 493 325 265 39 1.1k
Lauren K. Brais 866 461 230 259 39 1.2k
G.J. Poston 786 434 250 269 46 1.3k

All Works

Loading papers...

Rankless by CCL
2026